Trials / Completed
CompletedNCT01908348
Dose-Dependent Effects of Erythritol on Endothelial Function in Type 2 Diabetes Mellitus
Pilot Study: Dose Dependent Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Boston University · Academic / Other
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label pilot designed to examine the dose-dependent effects of erythritol, a zero calorie sweetener, on endothelial function. Twenty-four subjects with type 2 diabetes mellitus will make three study visits. At each visit, the will consume an orange-flavored beverage containing escalating amounts of erythritol (6, 12, and 18 grams). Endothelial function will be assessed before and two hours after beverage consumption. Endothelial function will be measured as the change in pulse amplitude in response to reactive hyperemia measured in the fingertip by peripheral arterial tonometry. The results will be used to plan a randomized, placebo-controlled study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Erythritol |
Timeline
- Start date
- 2013-07-18
- Primary completion
- 2014-12-01
- Completion
- 2016-12-01
- First posted
- 2013-07-25
- Last updated
- 2018-02-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01908348. Inclusion in this directory is not an endorsement.